Common use of Anti-Bribery Compliance Clause in Contracts

Anti-Bribery Compliance. The Parties undertake to comply with any applicable anti-bribery regulations and codes relating to anti-bribery and anti-corruption (the “Anti-Bribery Laws”), including but not limited to the US Foreign Corrupt Practices Act and the UK Xxxxxxx Xxx 0000. The Consultant is prohibited from offering or paying directly or indirectly anything of value to a government official or any other person, entity or institution covered under the Anti-Bribery Laws in order to: win or retain business for the Company; improperly influence an act or decision that will benefit the Company; gain an improper advantage for the Company. The Consultant undertakes to keep accurate and transparent records to reflect transactions and payments. Should the Consultant breach or have any reason to believe that they might have breached this section, they shall inform the Company immediately, in writing, and cooperate with Company to investigate and document the facts. The Consultant will notify the Company if the Consultant attains a position to influence purchasing decisions of a government entity of health-care-related institution (including a hospital, health board or any other institution of a similar nature). Such purchasing decisions may relate, for instance, to tenders issued by health authorities or decisions of formulary committees of public hospitals. In case of such notification by the Consultant, the Company has the right to terminate this Agreement with immediate effect by written notice. The Consultant shall also notify the purchase decision-maker in said institution of the Consultant’s financial relationship with the Company before any purchasing decision is made.

Anti-Bribery Compliance. The Parties undertake to comply with any applicable anti-bribery regulations and codes relating to anti-bribery and anti-corruption (the “Anti-Bribery Laws”), including but not limited to the US Foreign Corrupt Practices Act and the UK Xxxxxxx Xxx 0000. The Consultant Partner is prohibited from offering or paying directly or indirectly anything of value to a government official or any other person, entity or institution covered under the Anti-Bribery Laws in order to: win or retain business for the Company; improperly influence an act or decision that will benefit the Company; gain an improper advantage for the Company. The Consultant Partner undertakes to keep accurate and transparent records to reflect transactions and payments. Should the Consultant Partner breach or have any reason to believe that they it might have breached this section, they it shall inform the Company immediately, in writing, and cooperate with the Company to investigate and document the facts. The Consultant Partner will notify the Company if the Consultant Partner attains a position to influence purchasing decisions of a government entity of health-care-related institution (including a hospital, health board or any other institution of a similar nature). Such purchasing decisions may relate, for instance, to tenders issued by health authorities or decisions of formulary committees of public hospitals. In case of such notification by the ConsultantPartner, the Company has the right to terminate this Agreement with immediate effect by written notice. The Consultant Partner shall also notify the purchase decision-maker in said institution of the ConsultantPartner’s financial relationship with the Company before any purchasing decision is made.

Anti-Bribery Compliance. The Parties undertake to comply with any applicable anti-bribery regulations and codes relating to anti-bribery and anti-corruption (the “Anti-Bribery Laws”), including but not limited to the US Foreign Corrupt Practices Act and the UK Xxxxxxx Xxx 0000. The Consultant Speaker is prohibited from offering or paying directly or indirectly anything of value to a government official or any other person, entity or institution covered under the Anti-Bribery Laws in order to: win or retain business for the Company; improperly influence an act or decision that will benefit the Company; gain an improper advantage for the Company. The Consultant Speaker undertakes to keep accurate and transparent records to reflect transactions and payments. Should the Consultant Speaker breach or have any reason to believe that they might have breached this section, they shall inform the Company immediately, in writing, and cooperate with the Company to investigate and document the facts. The Consultant Speaker will notify the Company if the Consultant Speaker attains a position to influence purchasing decisions of a government entity of health-care-related institution (including a hospital, health board or any other institution of a similar nature). Such purchasing decisions may relate, for instance, to tenders issued by health authorities or decisions of formulary committees of public hospitals. In case of such notification by the ConsultantSpeaker, the Company has the right to terminate this Agreement with immediate effect by written notice. The Consultant Speaker shall also notify the purchase decision-maker in said institution of the ConsultantSpeaker’s financial relationship with the Company before any purchasing decision is made.